Orthofix Medical Inc... Show more
OFIX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 32 cases where OFIX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator entered the oversold zone -- be on the watch for OFIX's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OFIX advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 62 cases where OFIX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on May 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OFIX as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for OFIX turned negative on May 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .
The 50-day moving average for OFIX moved below the 200-day moving average on April 15, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OFIX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for OFIX entered a downward trend on May 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.877) is normal, around the industry mean (24.089). P/E Ratio (56.180) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.387) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.691) is also within normal values, averaging (42.249).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OFIX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OFIX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
a developer of surgical products to the spine and orthopedic markets
Industry MedicalSpecialties
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HEMCX | 9.15 | 0.02 | +0.22% |
Janus Henderson Emerging Markets C | |||
FAVAX | 23.25 | 0.02 | +0.09% |
Fidelity Advisor Equity Value A | |||
CAPFX | 8.52 | N/A | N/A |
Federated Hermes Capital Income F | |||
SVAAX | 5.98 | N/A | N/A |
Federated Hermes Strategic Value Div A | |||
NRMGX | 17.08 | -0.04 | -0.23% |
Neuberger Berman Mid Cap Growth R6 |
A.I.dvisor indicates that over the last year, OFIX has been loosely correlated with TCMD. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if OFIX jumps, then TCMD could also see price increases.
Ticker / NAME | Correlation To OFIX | 1D Price Change % | ||
---|---|---|---|---|
OFIX | 100% | -1.62% | ||
TCMD - OFIX | 49% Loosely correlated | -1.95% | ||
BVS - OFIX | 47% Loosely correlated | -1.76% | ||
GMED - OFIX | 43% Loosely correlated | -22.96% | ||
HBIO - OFIX | 42% Loosely correlated | +3.41% | ||
MMSI - OFIX | 41% Loosely correlated | -0.27% | ||
More |